definiens: means, with respect to a particular Exclusive Product or a particular LicensedProduct in a particular country, a pharmaceutical product that contains [ * * * ] and that is authorized for use in the country on thebasis of a less than full Drug Approval Application in reliance, in whole or in part, on safety or efficacy data submitted in supportof such Exclusive Product or such Licensed Product or on safety or efficacy findings with respect thereto, with or without anexpress right of reference or other authorization from [COMPANY] or [COMPANY], their respective Affiliates, or [COMPANY] ’s Sublicensees, including, for example, an abbreviated new drug application under Section 505(j ) or a new drug application under Section505(b)(2 ) of the FFDCA or any biosimilar application under Section 351(k ) of the U.S. Public Health Service Act or other U.S